3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Stomach Neoplasms
6
Peritoneal Neoplasms
6
Ovarian Neoplasms
4
Neoplasm Metastasis
4
Colorectal Neoplasms
3
Pancreatic Neoplasms
2
Neoplasms
2
Gastric Adenocarcinoma
2
Fallopian Tube Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Appendiceal Neoplasms
2
Uterine Neoplasms
1
Stomach Diseases
1
Pseudomyxoma Peritonei
1
Ovarian Epithelial Cancer Recurrent
1
Locally Advanced Gastric Cancer
1
Krukenberg Tumor
1
HIPEC
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Gastric Cancer Peritoneal Metastases
1
Digestive System Neoplasms
1
Clinical Stage I Gastric Cancer AJCC v8
1
Interventions
Methylprednisolone
3
Social Determinants of Health
2
trastuzumab deruxtecan
1
sacituzumab govitecan
1
pegaspargase
1
Vincristine
1
Temozolomide
1
Radiotherapy
1
Prednisone
1
Prednisolone
1
Pharmaceutical Services
1
Methylprednisolone Hemisuccinate
1
Methotrexate
1
Mercaptopurine
1
Leucovorin
1
Irinotecan
1
Infliximab
1
Hydrocortisone
1
Fecal Microbiota Transplantation
1
Etoposide
1
Drug Therapy
1
Doxorubicin
1
Dexrazoxane
1
Dexamethasone
1
Cytarabine
1
Cyclophosphamide
1
Cefixime
1
CTLA-4 Antigen
1
Asparaginase
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Drug-Related Side Effects and Adverse Reactions
×
Hyperthermic Intraperitoneal Chemotherapy
×
1 year
×
Clear all
No trials found.